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Maria Shishimorova, Ravindra N. Singh*
Department of Biomedical Sciences, Iowa State University, Ames, Iowa 50011, United States of America
* singhr@iastate.edu
Abstract
Humans carry two nearly identical copies of Survival Motor Neuron gene: SMN1 and
SMN2. Loss of SMN1 leads to spinal muscular atrophy (SMA), the most frequent genetic
cause of infant mortality. While SMN2 cannot compensate for the loss of SMN1 due to pre-
dominant skipping of exon 7, correction of SMN2 exon 7 splicing holds the promise of a
cure for SMA. Previously, we used cell-based models coupled with a multi-exon-skipping
detection assay (MESDA) to demonstrate the vulnerability of SMN2 exons to aberrant splic-
ing under the conditions of oxidative stress (OS). Here we employ a transgenic mouse
model and MESDA to examine the OS-induced splicing regulation of SMN2 exons. We
induced OS using paraquat that is known to trigger production of reactive oxygen species
and cause mitochondrial dysfunction. We show an overwhelming co-skipping of SMN2
exon 5 and exon 7 under OS in all tissues except testis. We also show that OS increases
skipping of SMN2 exon 3 in all tissues except testis. We uncover several new SMN2 splice
isoforms expressed at elevated levels under the conditions of OS. We analyze cis-elements
and transacting factors to demonstrate the diversity of mechanisms for splicing misregula-
tion under OS. Our results of proteome analysis reveal downregulation of hnRNP H as one
of the potential consequences of OS in brain. Our findings suggest SMN2 as a sensor of
OS with implications to SMA and other diseases impacted by low levels of SMN protein.
Introduction
Alternative pre-mRNA splicing plays an essential role in increasing the transcript diversity
from a single gene [1]. All human genes with two or more exons are alternatively spliced in one
or more tissues at one or more stages of development or distress [2]. Alternative splicing con-
fers immense variability to the functional RNA motifs (sequence and structural) with implica-
tions to RNA-protein interactions that regulate and facilitate post-transcriptional regulation of
gene expression, including RNA stability, RNA trafficking, mRNA translation, protein trap-
ping and chromatin remodeling. Splicing is catalyzed by the spliceosome, a complex and
dynamic machinery, comprised of hundreds of proteins that are differently assembled at
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different introns [3,4]. To add further complexity to the process, splicing is coupled with tran-
scription, 50-end capping and 30-end polyadenylation of RNA [5]. A combinatorial control by
cis-regulatory elements, RNA structure and transacting factors governs alternative splicing [6–
9]. Mutations within regulatory sequences cause defective splicing and result in genetic diseases
[10–12]. Genotoxic and oxidative stress (OS) conditions can also trigger aberrant splicing [13–
15]. However, the mechanism of OS-induced aberrant splicing remains poorly understood.
Humans have two nearly identical Survival Motor Neuron (SMN) genes; SMN1 and SMN2
[16]. A full-length (FL) transcript and FL SMN protein are the major products of the SMN1
gene, whereas the SMN2 gene predominantly generates a truncated transcript and a truncated
protein (SMNΔ7) due to skipping of exon 7 [17]. Unlike SMN, SMNΔ7 is only partially func-
tional and highly unstable [18,19]. SMN plays a role in a variety of cellular processes, including
transcription, snRNP biogenesis, DNA recombination, stress granule formation, vesicular
transport, signal transduction, and motor neuron trafficking [20]. Deletion of and/or muta-
tions in SMN1 coupled with the inability of SMN2 to compensate for the loss of SMN1 leads to
spinal muscular atrophy (SMA), a leading genetic disease of children and infants [21–23]. Mice
contain a single Smn gene, which is equivalent to SMN1. Consistent with the indispensable
nature of SMN, deletion of Smn gene leads to embryonic lethality [24]. However, introduction
of SMN2 into the null Smn-/- background recapitulates a SMA phenotype [25]. While the role
of SMN2 remains elusive, it serves as a promising target for SMA therapy by compounds that
elevate the levels of SMN by enhancing SMN2 transcription and/or by correcting SMN2 exon 7
splicing [20–22,26,27]. Since SMN2 contributes towards the overall cellular pool of SMN, its
copy number impacts the severity of SMA [25,28]. Evidence is emerging that SMN serves as a
disease-modifying factor in other neurodegenerative disorders, including Parkinson’s disease
and amyotrophic lateral sclerosis [29–31]. A recent study suggests a high level of SMN is
required for the testicular development and male fertility [32].
OS is linked to several chronic conditions including cancer, cardiovascular diseases and neuro-
degenerative diseases [33]. Paraquat (PQ, 1,10-dimethyl-4,40-bipyridinium dichloride) is an envi-
ronmental toxin and OS stimulant that is widely implicated in reactive oxygen species formation
and mitochondrial dysfunctions [34–36]. PQ is commonly used in cell- and animal-based models
to study the pathogenesis of Parkinson’s disease as well as to uncover the mechanism by which
OS impacts various cellular processes [37–39]. However, the mechanism by which PQ causes
splicing defects is poorly understood. A previous study has shown increased skipping of SMN2
exons 5 and 7 in neuronal cells treated with PQ [40]. Employing a multi-exon-skipping detection
assay (MESDA), we have recently demonstrated that splicing of multiple exons of SMN1 and
SMN2 are affected by PQ-induced OS in both neuronal and non-neuronal cells [41]. Findings of
these studies provide a clue that various SMN exons may be differently affected in different tissues
subjected to PQ-induced OS. However, there is no in vivo study on how PQ affects tissue-specific
splicing of various exons of SMN or any other gene harboring multiple skipping exons.
Here we examine the body-wide impact of PQ-induced OS on splicing of various SMN2
exons in a healthy transgenic mouse model carrying the SMN2 transgene. Our MESDA results
reveal tissue-specific signatures of SMN2 splice isoforms generated by OS. We analyzed cis-ele-
ments and transacting factors to uncover likely mechanisms by which splicing of various exons
are impacted by OS.
Materials and Methods
Study approval
All experiments with mice and experimental guidelines were approved and monitored by the
Institutional Animal Care and Use Committee (IACUC) at Iowa State University (Ames, IA,
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USA) following the federal and state guidelines. This study is designed to address how OS
affects tissue-specific splicing regulation in mice exposed to PQ that is known to increase sus-
ceptibility to Parkinson’s disease.
Animals
For all mice experiments, male and female mice were housed under the standard conditions of
constant temperature (22 ± 1°C), humidity (relative, 30%) and a 12 h light/dark cycle. All mice
had free access to food and water. Transgenic (TG) mice with FVB/N background, which have
two copies of SMN2 and one copy of Smn (Smn+/-;SMN2+/+), were generated from breeding
pairs obtained from the Jackson Laboratory (JAX Strain 005024) [25]. Ear punches were used
for genotyping.
Design of in vivo experiments with paraquat
Each animal group treated with either phosphate buffered saline (PBS) (Life Technologies,
Carlsbad, CA) or paraquat (PQ, 1,10-dimethyl-4,40-bipyridinium dichloride hydrate or methyl
viologen dichloride hydrate, Sigma-Aldrich, St. Louis, MO) consisted of four 6–8 week-old TG
mice: two male (~23 g each) and two female (~17 g each). PQ stock solution was prepared
immediately before usage (200 mM in PBS). In PQ-treated group every individual mouse
received a single injection (0.25 ml) of various amounts of PQ ranging from 10 to 70 mg/kg
body weight using intraperitoneal (IP) route, similar to the dose range used in [42,43]. In PBS-
treated control group, each mouse was given an IP injection of PBS (0.25 ml). Once injected,
mice were monitored twice per day until their sacrifice. At the designated time points, mice
were anaesthetized using isoflurane and sacrificed by cervical dislocation. Mouse tissues,
including brain, heart, kidney, liver, lung, muscle, spinal cord, testis, and uterus/ovary, were
collected and immediately frozen either in liquid nitrogen or on dry ice and moved to -80°C
for storage until further usage.
Survival study
Each 6–8 week-old TG mouse was randomly divided into two groups: control group (PBS
injection, n = 10) and PQ group (70 mg/kg, n = 28). We chose the highest dose based on a pre-
vious study [43]. Mice were housed in groups of 3–4 same conditions as described above and
provided with soaked standard laboratory food. Mice were monitored twice per day and eutha-
nized if they showed signs of excessive pain or distress, including reduced motor activity.
Unless otherwise stated, all experiments were terminated at 24 hours post PQ treatment. This
termination time point was chosen based on the time course experiment that captured all splic-
ing events affected by PQ-induced OS. At the termination point, mice were anaesthetized
using isoflurane and sacrificed by cervical dislocation. All reasonable effort were made to mini-
mize animal suffering, including anesthesia.
Reverse transcription and MESDA
Total RNA was isolated from mouse tissues using TRIzol reagent (Life Technologies) following
the manufacturer’s recommendations. RNA was subjected to DNase digestion using RQ1
RNase-free DNase (Promega, Madison, WI). DNase-treated RNA was recovered by either phe-
nol:chloroform (OmniPur) extraction and ethanol precipitation or by using a Qiagen RNeasy
Mini RNA purification kit (Qiagen, Venlo, Netherlands). RNA concentration was measured
using a NanoDrop spectrophotometer (Thermo Scientific, Carlsbad, CA). cDNA was reverse
transcribed from 1.6 μg of total RNA in a 10 μl reaction, using a SuperScript III Reverse
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Transcriptase (RTase, Life Technologies) and oligo(dT)12-18 primer (Life Technologies), ran-
dom primers (Promega), or a gene-specific primer (3E8-Dde) for SMN2 analysis. For mouse
Smn analysis a gene-specific primer (3SmnE8) was used. One or two μl of RTase reaction were
then used as a template for PCR amplification in a 25 μl reaction with Taq DNA Polymerase
(New England Biolabs). The reaction was carried out in the presence of either a 50-end-32P-
labelled primer or a trace amount of [α-32P] dATP (3,000 Ci/mmole; Perkin-Elmer, Waltham,
MA). MESDA was performed as previously described [41]. PCR products were resolved on
native polyacrylamide gels. Analysis and quantifications of splice products were performed
using a FPL-5000 Image Reader and Multi Gauge software (Fuji Photo Film Inc, Valhalla, NY).
Total RNA from cultured cells was prepared using TRIzol reagent (Life Technologies) fol-
lowing the manufacturer’s instructions. Reverse transcription reactions were carried by Super-
Script III RTase. For amplification of SMN and SBP2, cDNAs were generated using gene-
specific primers 3E8-Dde and 3hSBP2E4, respectively (S1 Table). For MESDA, cDNA was
amplified using Taq DNA polymerase and a pair of primers 5SMNE1TSS and 3E8-25 (S1
Table), with the latter one being 32P-labeled at its 50 end. 2 μl of RTase reaction were used per
25 μl of PCR reaction. RT-PCR amplified SMN splice products were resolved on native poly-
acrylamide gels. Analysis and quantifications were then performed using a FPL-5000 Image
Reader and Multi Gauge software (Fuji Photo Film Inc). For SBP2, PCR amplification was
done using primers 5hSBP2E1 and 3hSBP2E4 (S1 Table). RT-PCR amplified SBP2 splice iso-
forms were resolved on native polyacrylamide gels. The gels were stained with ethidium bro-
mides and the fluorescent images captured using the BioSpectrum AC Imaging System (UVP,
Upland, CA). Primers used for RT-PCR and MESDA are given in S1 Table. Novel splice iso-
forms of SMN2 are described in Table 1.
Table 1. Description of SMN splice variants.
Exon Gene GenBank accession number Reference
ΔC3,7 SMN2 KF217140 This study
ΔC3,5,7 SMN2 KF217141 This study
ΔC5,6,7 SMN2 KF217142 This study
ΔC3–5,7 SMN2 KF217143 This study
ΔC3,5–7 SMN2 KF217144 This study
ΔC3–7 SMN2 KF217145 This study
ΔC5 SMN1 JQ657798 [41]
ΔC3 SMN1 JQ657800 [41]
ΔC5,7 SMN1 JQ657799 [41]
ΔC5,6,7 SMN1 JQ657801 [41]
ΔC5,6 SMN1 JQ732166 [41]
ΔC5,6 SMN2 JQ732167 [41]
ΔC5 SMN1 JQ657802 [41]
ΔC3 SMN2 JQ690861 [41]
ΔC3,4 SMN1 JQ745297 [41]
ΔC4,7 SMN2 JQ690864 [41]
ΔC3,7 SMN2 JQ690862 [41]
ΔC3,5 SMN1 JQ657803 [41]
ΔC3,5,7 SMN2 JQ690863 [41]
ΔC5,7 SMN2 JQ690865 [41]
ΔC3,7 SMN1 JQ690867 [41]
ΔC3,5 SMN2 JQ690866 [41]
ΔC3,5,7 SMN1 JQ690868 [41]
doi:10.1371/journal.pone.0154390.t001
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Quantitative Real-time PCR (QPCR)
All reactions were performed in 96-well plates using the Stratagene Mx3005P PCR machine
(Agilent technologies, Santa Clara, CA). cDNA was synthesized as described above using either
oligo(dT)12-18 or random primers. Each RTase reaction was then diluted 1:20, and 1.5 μl was
used in a 20 μl of PCR reaction containing 300 nM of each primer and either Brilliant II SYBR
master Mix with Rox (Agilent Technologies) or FastStart Universal SYBR Green Master mix
(ROX) (Roche, Basel, Switzerland). For a negative control, cDNA synthesized in absence of
RTase or nuclease-free water was used as a template during QPCR amplification. The amplicon
sizes were< 200 bp. Genes showing threshold cycle values greater than 38 were considered as
undetectable/less expressed. To amplify different splice isoforms and to avoid amplification of
genomic DNA, at least one primer in each primer set used for QPCR was designed to anneal to
an exon-exon junctions. Each isoform abundance was calculated relative to the average of three
samples from PBS-treated animals using the ΔΔCt method. Values were normalized by divid-
ing by the geometric mean of the abundance of three genes: β-actin (ACTB), Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH), and Hydroxymethylbilane synthase (HMBS), ampli-
fied with primers described [44]. All samples were used in three biological replicates and ampli-
fied in technical duplicates.
Western blot analysis
For animal tissues, frozen samples were thawed on ice and very briefly rinsed in ice-cold
1XPBS. Tissues were then homogenized in ice-cold Radioimmunoprecipation Assay (RIPA)
buffer (Boston BioProducts, Ashland, MA) using the ratio of 100 μl of RIPA buffer per 10 mg
of tissue. Immediately before usage, RIPA buffer was supplemented with either Halt protease
single use inhibitor cocktail or Halt protease and phosphatase inhibitor cocktail (Thermo Sci-
entific, Waltham, MA). Samples were then sonicated (6 times, 10 sec each, with 1 min inter-
vals) and kept on ice for 30 min. The obtained lysates were subjected to centrifugation at
12,000 rpm for 30 min at 4°C to remove tissue debris. For cells grown in culture total protein
lysates were prepared similar as described in [41]. Briefly, cell pellets were resuspended in ice-
cold RIPA buffer (Boston BioProducts) supplemented with Halt protease and phosphatase
inhibitor cocktail (Thermo Scientific). Resuspended cells were left on ice for 30 min, after what
the lysates were spun down at 13,000 rpm for 10 min at 4°C to remove cell debris.
Protein concentrations were measured by Bradford protein assay using Bio-Rad protein
assay solution (Bio-Rad, Hercules, CA). Protein samples were resolved on SDS-polyacrylamide
gels. The separated proteins were transferred to Immobilon polyvinylidene fluoride (PVDF)
membrane (Millipore, Billerica, MA) using the Turbo Transfer system (Bio-Rad). Membrane
blocking was done in 5% nonfat dried milk in Tris-buffered saline with 0.05% Tween-20
(TBST). The following primary antibodies were used: mouse anti-SMN-KH antibody (1:500;
Millipore), mouse monoclonal anti-SMN antibody (1:2,000, BD Transduction Laboratories, E.
Ruthorford, NJ; cat # 610646), mouse anti-Gemin2 (1:500; Sigma-Aldrich; Clone 2E17, cat #
G6669), rabbit polyclonal anti-elF4A2 (1:1000; Abcam, Cambridge, MA; ab31218), mouse
monoclonal anti-SRPK2 (1:4000; BD Transduction Laboratories; cat # 611118), mouse mono-
clonal anti-phosphorylated SR proteins (1:200; Millipore; anti-phospho epitope SR proteins
clone 1H4), rabbit monoclonal anti-PSF (1:10,000; Abcam; EPR11847, ab177149), goat poly-
clonal anti-p54 (1:3,000; Santa Cruz Biotechnology, Dallas, TX, C-16, sc-46220), rabbit poly-
clonal anti-SRp55 (1:200; Santa Cruz Biotechnology; H-180, sc-67100), mouse monoclonal
anti-hnRNP A1 (1:10,000; Abcam; 9H19, ab5832), mouse monoclonal anti-hnRNP A2
(1:2,000; Abcam; DP3B3, ab6102), rabbit monoclonal anti-hnRNP K (1:10,000; Abcam;
EP943Y, ab52600), mouse monoclonal anti-ASF/SF2 (1:400; US Biological Life Sciences,
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Salem, MA; S5555), goat polyclonal anti-TIA-1 (1:500, Santa Cruz Biotechnology; C-20, sc-
1751), goat polyclonal anti-TIAR (1:200; Santa Cruz Biotechnology; C-18, sc-1749), goat poly-
clonal anti-hnRNP H (1:200; Santa Cruz Biotechnology; N-16, sc-10042), horseradish-peroxi-
dase-conjugated anti-FLAG (1:4,000; Sigma-Aldrich; A8592), rabbit polyclonal anti-β-Actin
(1:2,000; Sigma-Aldrich; A2066), mouse monoclonal anti-GAPDH (1:5,000; Abcam; 6C5,
ab8245), rabbit monoclonal anti-Akt (1:1,000; Cell Signaling, Danvers, MA; C67E7, cat # 4691)
and rabbit monoclonal anti-phospho-(Ser473)-Akt (1:1,000; Cell Signaling; D9E, cat # 4060).
After incubation with primary antibodies, membranes were washed in TBST at least four times
(10 min each) and incubated with the appropriate secondary antibody. The following second-
ary antibodies were used: horseradish-peroxidase-conjugated goat anti-mouse IgG (1:5,000;
Jackson Immuno Research, West Grove, PA; cat # 115-035-003), donkey anti-rabbit IgG
(1:2,000; GE Healthcare, Pittsburgh, PA; cat # NA934V) and donkey anti-goat IgG (1:2,000;
Santa Cruz Biotechnology; sc-2020). Following multiple washes with TBST, membranes were
developed using SuperSignal West Dura Extended Duration Substrate or SuperSignal West
Femto Maximum Sensitivity Substrate (Thermo Scientific) following the manufacture’s
instructions. Images were visualized using the BioSpectrum AC Imaging System (UVP). Often
membranes were stripped using Restore Western Stripping Buffer (Thermo Scientific) and re-
probed.
To detect 4-Hydroxynonenal adducts of histidine residues the membranes were incubated
with primary mouse monoclonal anti-4-HNE antibody (R&D Systems, Minneapolis, MN;
Clone #198960, MAB3249). Alexa Fluor 680-conjugated goat anti-mouse antibody (Thermo
Scientific) was used as a secondary antibody. Western blot images were captured with a
LI-COR Odyssey machine (LI-COR, Lincoln, NE).
For each Western blot, the mean intensity of each band was determined using ImageJ soft-
ware. The mean intensity of the band of interest for each sample was divided by the mean
intensity of β-actin, which served as a loading control. For comparisons purposes, the PBS
average was set at 1.0 and PQ samples were expressed relative to this value.
Sample preparation for isoelectric focusing (IEF)
TG brain tissues were homogenized in ReadyPrep Protein Extraction Kit (Bio-Rad) following
the manufacturer’s instructions. Briefly, 100 mg of brain tissue was homogenized in the pres-
ence of 1 ml 2D Rehydration buffer containing protease inhibitors. This was followed by soni-
cation (four times, 30 sec each with an interval of 30 sec). Lysates were clarified by
centrifugation at 16,000 x g for 30 min at room temperature. The extracted proteins were
cleaned up by acetone precipitation methods (TECH TIP#49, Thermo Scientific) and the con-
centration of proteins was measured via Bradford protein assay as described above.
Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE)
Isoelectric focusing (IEF) (pH3-10, 18 cm strip) using 500 μg of each sample was conducted in
rehydration solution (8M Urea, 2% CHAPS, 0.5% immobilized pH gradients buffer, bromo-
phenol blue containing 2.8 mg/ml DTT) at 20°C using the GE electrophoresis unit in accor-
dance with the manufacturer’s instructions. After the IEF procedure, strips were incubated for
10 min with equilibration buffer (50 mM Tris-HCl, pH 8.8, 6M urea, 30% glycerol, and 2%
SDS, bromophenol blue containing 10 mg/ml DTT). Equilibrated strips were then inserted
onto SDS-PAGE gels (20 x 24 cm, 15%) and 2D gels were run. Upon run completion, the 2D
gels were subjected to Coomassie Blue staining. Digital images from Coomassie stained gels
were acquired using the Amersham Pharmacia Biotech ImageScanner flatbed scanner. Digita-
lized images were quantitatively analyzed using Progenesis SameSpots in accordance with the
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manufacturer’s instructions. Each spot was normalized by total valid spot intensity and the
spots with a fold change greater than 2, an anova (p) less than 0.05 and a power greater than
0.8 were selected. Selected protein spots were enzymatically digested. Trypsin fragments were
then analyzed using Matrix Assisted Laser Desorption/Ionization-Time of Flight (MALDI-
TOF). Sequence tag searches were conducted using the MASCOT program.
Cell culture
All the tissue culture supplies were from Life Technologies. Human HEK-293 cells were grown
in Dulbecco’s Modified Eagle’s Medium (DMEM, cat # 11965) supplemented with 10% Fetal
Bovine Serum (FBS). Human neuroblastoma SH-SY5Y cells were cultured in 1:1 mixture of
Minimum Essential Medium (MEM, cat #11095) and F12 Medium (cat # 11765) supplemented
with 10% FBS. Human primary fibroblasts from SMA type I patient (GM03813) obtained from
Coriell Cell Repositories were cultured in MEM (cat # 10370) supplemented with 2 mM Gluta-
MAX-I (cat # 35050) and 15% FBS.
For PQ treatment of HEK-293, cells were pre-plated in 100 mm dishes at a density of
~1.9X106 cells. For PQ treatment of SH-SY5Y and GM03813, cells were pre-plated in 60 mm
culture dishes at a density of 4.2X106 and 3.3X105 per dish, respectively. Next day (24 hours
later) medium in each dish was replaced with a fresh one without (-) or with (+) 1mM PQ.
24 hours later cells were washed with ice-cold 1XPBS (3 times) and collected by scraping. One
sixth of the cells were used for total RNA preparation, while the rest of the cells were lysed
using RIPA buffer.
HeLa cells were grown in DMEM (cat # 11965) supplemented with 10% FBS. To test
whether different splice isoforms can be translated, HeLa cells pre-plated at a density of
~0.4x106 cells per one well of a 6-well plate were transfected with 2 μg of 3XFLAG-tagged pro-
tein expression vector of interest using X-tremeGENE HP DNA transfection Reagent (Life Sci-
ence) following the manufacturer’s recommendations. Twenty-four hours later, HeLa cells
were washed with ice-cold 1X PBS (3 times) and collected by scraping for whole-cell lysate
preparation using RIPA buffer similar as in [41].
Generation of SMN splice isoform expression vectors
Human expression vectors for 3XFLAG-tagged SMN splice isoforms were generated as follows
(S3 Table). cDNA of interest was reverse transcribed using total RNA from TG brain or
SH-SY5Y cells, Super ScriptIII Reverse Transcriptase (Life Technologies) and either 3Adapter-
oligo(dT) primer or a gene-specific primer (3E8-Dde). PCR amplification of each SMN isoform
was performed with a pair of primers, 5SMNE1-MluI and P2-2 (S1 Table). The SMN2 30UTR
sequences were amplified using the primers 5SMNE8-St and 3Adapter-SalI. PCR products
were gel-purified and used as templates together with the 30UTR fragment for the second PCR
with primers 5SMNE1-MluI and 3Adapter-SalI. PCR products were then digested with MluI
and SalI and inserted into human 3XFLAG mammalian expression vector [45]. The identity of
generated expression vectors was verified by sequencing.
Motif analysis
Multiple EM for Motif Elicitation (MEME) package (version 4.11.1) [46] was used to identify
over-represented motifs (4–6 width motif with more than 4 site counts) in exons with
increased exclusion or inclusion upon PQ treatment. Analyses were performed with a search
window of entire OS-induced aberrant splicing exons and 100 nt flanking intronic sequences.
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Statistical analysis
For Kaplan-Meier survival curves, log-rank tests were used. For QPCR, relative quantities with
standard error were calculated by using ΔΔCTmethod in Excel (Microsoft Office 2011 edition).
Statistical analyses were performed using the Student’s t-test. Unless otherwise mentioned, P
values were two-tailed and the level of statistical significance was set at P< 0.05.
Results
Time and dose-dependent signatures of oxidative-stress-induced splice
isoforms of SMN2
To analyze the impact of OS on splicing of SMN2 pre-mRNA in vivo, we used a previously
described transgenic (TG) mouse model that carries the human SMN2 transgene on the Smn+/-
background [25]. Since the Smn gene is equivalent to human SMN1, this TG model is ideal for
testing the impact of OS on SMN2 splicing in the presence of normal levels of SMN protein. To
induce OS in vivo and reliably capture the majority of splicing events at early time points, we
treated TGmice with a single intraperitoneal (IP) injection of 70 mg/kg of PQ. This dose was
selected based on a previous study [43]. Of note, barring few exceptions, most mice survived
beyond 24 h of the PQ treatment (S1A Fig). Since we did not observe gender-specific differences
in SMN2 splicing outside the sex organs, males and females were analyzed together. Each treat-
ment group was comprised of four animals: two males and two females. To confirm that OS con-
ditions were induced in PQ treated mice, we monitored the level of 4-hydroxynonenal (4-HNE)
adducts and phosphorylated AKT (pAKT) in brain samples. Both 4-HNE and pAKT are consid-
ered markers of OS [47,48]. Confirming the OS status in the brain, we observed an increase in
the levels of 4-HNE and pAKT as early as 8 hours after PQ administration (S1B and S1C Fig).
To capture the earliest effect of OS on splicing of SMN2, we performed MESDA using liver
samples harvested at different time points post PQ injection. Liver was chosen based on a con-
sideration that it would have the fastest uptake of PQ delivered through IP route. To reduce the
background, we used SMN2-specific primer to generate cDNA. As shown in Fig 1B, OS-
induced changes in splicing of SMN2 appeared as early as 8 h post PQ injection. In particular,
we observed more than 50% decrease in the levels of the FL transcript, with a concomitant
2-fold increase in co-skipping of exons 5 and 7, while skipping of exon 7 increased by ~15%
(Fig 1B). At 12 h post PQ treatment, the relative amount of splice isoforms remained similar to
that of 8 h post PQ treatment (Fig 1B). However, at 24 h time point, there was a near total loss
of the FL transcript accompanied by further increase in co-skipping of SMN2 exons 5 and 7
(Fig 1B). At 36 h post PQ treatment, the levels of the FL transcript began to increase with
simultaneous reduction in the levels of Δ5,7 transcripts; however, transcript levels were not
fully restored even 48 h after PQ injection (Fig 1B). These results underscore that co-skipping
of SMN2 exons 5 and 7 is a signature event of PQ-induced OS observed during the first 24 h of
treatment. Interestingly, 70 mg/kg treatment resulted in noticeably higher levels of Δ3–7 and
Δ3–5,7 transcripts 8 and 12 h post injection, respectively, in two out of 20 samples (Fig 1B,
lanes 7 and 9). We also detected several faint bands corresponding to splice isoforms in which
multiple exons were simultaneously skipped; most of these isoforms lacked exon 3 and/or exon
5 (Fig 1B). Our results also revealed novel splice isoforms generated during the conditions of
OS, such as Δ5–7, Δ3,5–7, Δ3–5,7 and Δ3–7 (Fig 1B, marked with pound signs). GenBank
accession numbers of various SMN splice isoforms generated under normal and OS conditions
are given in Table 1.
Based on our results described above we chose 24 h post PQ injection as the time point to
collect samples for analysis of all aberrantly spliced SMN2 variants. Of note, we did not take
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later time points to avoid the impact of secondary effects on splicing. The effect of PQ-induced
OS on splicing of various SMN2 exons was minimal, marginal and substantial at low (10 mg/
kg), medium (25 mg/kg) and high (50 mg/kg) doses of PQ, respectively (Fig 1C). At 50 mg/kg
treatment, we detected greatly increased levels of Δ5,7, Δ3,7 and Δ3,5,7 splice variants in liver
of one out of four animals (Fig 1C, lane 15). These findings underscore individual variations in
susceptibility of SMN2 exons to skipping under OS. Overall, our results confirmed that co-
skipping of exons 5 and 7 is the hallmark of SMN2 aberrant splicing under the severe condi-
tions of OS (50 and 70 mg/kg PQ treatment). However, under milder OS conditions induced
by lower PQ (25mg/kg), increased skipping of SMN2 exon 7 was the major event (Fig 1C).
Tissue-specific effect of oxidative stress on splicing of various exons of
SMN2
We next examined the tissue-specific effect of OS on splicing of SMN2 exons. We performed
this analysis on various tissues collected 24 h post PQ injection (70 mg/kg; IP route). A repre-
sentative example of MESDA is shown in Fig 2A. As expected, the Δ7 transcript was the major
splice isoform in brain, heart, kidney, liver, lung, muscle and spinal cord of untreated animals,
followed by the FL transcript (Fig 2A). The relative amount of Δ5,7 variant was a distant third
in all untreated samples. However, we observed a near total disappearance of the FL transcript
accompanied by an increase in the levels of Δ5,7 transcript in all organs and tissues harvested
from PQ-treated mice (Fig 2A). Co-skipping of exon 5 and 7 was highest in brain and spinal
cord (4 and 3.5 times increase, respectively) and lowest in heart and muscle (~ 2 times increase)
(Fig 2A). Interestingly, heart and muscle were the only two organs in which PQ treatment
resulted in a more than 10% increase in individual skipping of exon 7 (Fig 2A, Δ7 transcript).
The levels of individual skipping of exon 5 and exon 3 were extremely low across all samples
tested. Visual inspection of the gel indicated that PQ treatment decreased individual skipping
of exon 5 and exon 3 (Fig 2A). With respect to the shorter splice variants, the levels of Δ3,7 and
Δ3,5,7 transcripts were affected the most, particularly in lung (Fig 2A). However, these tran-
scripts represented only a very small fraction of SMN2 splice isoforms. As for the novel splicing
events, the conditions of OS led to a small but noticeable increase in co-skipping of exons 5, 6
and 7, particularly in spinal cord (Fig 2A). At the same time, the levels of other novel splice var-
iants, such as Δ3–7, Δ3,5–7 and Δ3–5,7 appeared to be largely unaffected by OS. When
MESDA was performed with primers specific to mouse Smn, no effect of OS on splicing of any
of the mouse Smn exons was observed in any of the tissues tested (Fig 2B).
To independently validate the results of MESDA, we analyzed transcripts by PCR employ-
ing primers that annealed to flanking exonic sequences of each individual alternatively spliced
exon. Here again, we used SMN2-specific primers to generate cDNA. We first examined the
splicing pattern of SMN2 exon 7 that has the highest propensity of skipping under normal and
Fig 1. Time and dose dependent effects of PQ treatment on splicing of SMN2 exons in the liver of TGmice. (A) Diagrammatic representation of the
human SMN2 gene. Exonic sequences are shown as boxes or ovals, whereas intronic sequences are shown as lines/broken lines. Annealing positions of
primers used for MESDA are shown. Lengths of exons and introns are given in bp. Sizes of exons and introns are not to scale. (B) Detection of multiple exon
skipping events of SMN2 at different time points in liver. TGmice were IP injected with PQ (70 mg/kg) and liver was harvested at the indicated time points.
For each time point, the first two lanes are males and the next two lanes are females. Splice products were analyzed by MESDA [41]. Splice variants are
marked on the left and right sides of the gel. The identities of splice variants were established by sequencing. Pound signs next to splice variants mark novel
isoforms (Table 1). Bar diagrams showing the relative abundance of individual transcripts as percent of total and the fold change are presented at the bottom
of the gel. For fold change, the level of mRNA from the 0 h group was normalized to a value of 1. Error bars represent standard errors. Stars above PQ bars
indicate statistical significance (*, P < 0.05; **, P < 0.01). Abbreviations: FL, full-length transcript; Δ, transcript lacking an exon(s); #, novel splice isoform; h,
hour. (C) MESDA of SMN2 at various PQ concentrations. Liver samples were harvested at 24 h post PQ injection. PQ concentrations are given at the top of
the gel. At any given dose, the first two lanes are males and the next two lanes are females. Labeling and descriptions of bar diagrams are the same as in
panel B.
doi:10.1371/journal.pone.0154390.g001
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OS conditions (Fig 2A, lanes 1–14). Confirming the results of MESDA, we observed over-
whelming skipping of SMN2 exon 7 in tissues harvested from the PQ-treated animals (S2B
Fig). We next determined the splicing pattern of SMN2 exon 5 by PCR using forward and
reverse primers that annealed to exons 4 and 6, respectively. Consistent with the results of
MESDA, PQ-induced OS caused small but noticeable skipping of SMN2 exon 5 in all tissues
tested (S2C Fig). Finally, we examined splicing of SMN2 exons 2a, 2b and 3 by PCR employing
forward and reverse primers that annealed to exons 1 and 4, respectively. PQ-induced OS pro-
duced small but noticeable skipping of SMN2 exon 3 in all tissues examined (S2D Fig). Once
again, these findings were consistent with the results of MESDA. Parallel experiments on Smn
did not show any noticeable effect of OS on splicing of exons 3, 5 and 7 in any tissue examined
(S2B–S2D Fig).
While MESDA revealed susceptibility of various SMN2 exons to skipping under OS, we did
not identify an OS-induced usage of an alternative splice site (ss) within any of the SMN2
exons. We have previously shown the usage of an alternative 30 ss within exon 3 of Secis-Bind-
ing Protein 2 (SBP2) transcripts [49]. SBP2 is a housekeeping gene responsible for the synthesis
of selenoproteins in higher organisms [50]. SBP2 is also implicated in prolonging cell survival
under OS [51]. We used Sbp2 as a model to examine the OS-induced usage of the alternative 30
ss in various tissues of TG mice. Of note, usage of an alternative 30 ss within exon 3 causes skip-
ping of exon 3a (the 50 portion of exon 3), leading to the generation of a SBP2 isoform targeted
to the mitochondria (Fig 2C) [49]. Our results show that PQ treatment enhanced skipping of
Sbp2 exon 3a in brain, kidney, muscle and spinal cord of TG mice (Fig 2C). We also observed
the highest increase in skipping of exon 3 in lung of PQ-treated TG mice (Fig 2C). The kidney
emerged as a unique tissue in which PQ enhanced skipping of both exons 3 and 3a (Fig 2C).
Interestingly, OS did not affect either of these exons in liver, suggesting that factors responsible
for the skipping of exons 3 or 3a are absent in this tissue (Fig 2C). Skipping of exon 3a in brain
and several other tissues is possible only when the 30 ss of exon 3b is strengthened with respect
to the 30 ss of exon 3. While intronic and exonic sequences at the 30 ss of exon 3 are represented
by U- and A-rich motifs, respectively, intronic and exonic sequences at the 30 ss of exon 3b are
represented by C-rich motifs (S3A Fig). Both exons 3 and 3b of Sbp2 share the same 50 ss that
forms extensive base pairing with U1 snRNA, a component of U1 snRNP (S3B Fig); however,
the 50 ss of exons 3/3b is predicted to be sequestered in a stem-loop structure that may in part
account for an OS-induced skipping of Sbp2 exon 3 in kidney and lung (S3C Fig). In contrast
to the skipping of SMN2 exon 7, none of the exons of Sbp2 showed universal skipping under
OS. Of note, there are noticeable differences between mouse and human SBP2 exon 3 and
flanking intronic sequences (S3A Fig). Consequently, we did not observe any PQ-induced skip-
ping of SBP2 exon 3a in human neuronal SH-SY5Y cells (S3D Fig). We also determined splic-
ing of SBP2 exons 3/3a in cultured HEK-293 cells treated with PQ. Considering HEK-239 cells
are derived from human embryonic kidney, the splicing pattern of SBP2 exons 3/3a was consis-
tent with splicing of mouse Sbp2 exons 3/3a in kidney (compare S3D Fig with Fig 2C). These
results suggest that motifs responsible for the kidney-specific splicing regulation of SBP2 exons
3/3a are conserved between human and mice.
Fig 2. Effect of PQ treatment on splicing of SMN2, Smn and Sbp2 in various tissues of a representative TGmouse. (A) MESDA of SMN2 in different
tissues harvested from a TGmouse treated with PBS or PQ (70 mg/kg). Samples were harvested at 24 h post PQ injection. Types of tissues are indicated on
the top of the gel. Labeling and other descriptions are the same as in Fig 1B. Percentages of major splice isoforms are given at the bottom of the gel. They
were calculated from the total value of FL, exon 7-skipped and exon 5,7-skipped products. Abbreviations: BRN, brain; HRT, heart; KDN, kidney; LVR, liver;
LNG, lung; MSL, muscle; SPC, spinal cord. (B) MESDA of Smn in different tissues harvested from the samemouse as in panel A. No skipping of Smn exons
was detected. Abbreviations are the same as in panel A. (C) Splicing pattern of Sbp2 exon 3/3a in different tissues harvested from the samemouse as in
panel A. Percentages of skipping of exon 3 and 3a are indicated at the bottom of the gel. They were calculated from the total value of FL, exon 3a-skipped
and exon 3-skipped products. Diagrammatic representation of Sbp2 alternative splicing under normal and OS conditions is given in the top panel.
doi:10.1371/journal.pone.0154390.g002
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Oxidative stress alters the cumulative frequency of several splicing
events
To analyze the cumulative frequency of skipping of a specific SMN2 exon, we employed quanti-
tative real-time PCR (QPCR). To determine the levels of total SMN2 transcripts, we used for-
ward and reverse primer that annealed to exon 1 and the exon 1/exon 2a junction, respectively
(Fig 3A). We chose this primer combination based on the fact that neither exon 1 nor exon 2a
is alternatively spliced (S2D Fig). To evaluate one- or two-exon skipping events, we used
primer sets in which at least one primer annealed to an exon-exon junction (Fig 3A). Of note,
using a wild type mouse as a control, we confirmed that our primer combinations do not
amplify Smn transcripts. Final values were normalized against the geometric mean of three
non-fluctuating controls in the same tissue [44]. The results were expressed in terms of relative
abundance of transcripts in normal and OS conditions (Fig 3B). Since oligo(dT)12-18 was used
to prepare cDNA, all transcripts analyzed in this study were polyadenylated. Our results
revealed that PQ-induced OS does not alter the overall levels of SMN2 transcripts in any tissue
except heart, where a small but statistically significant increase was observed (Fig 3B). Consid-
ering data were normalized against the internal controls, our results of QPCR should be inter-
preted with caution. For instance, a general decline in the rate of transcription due to an energy
deficit created by OS will not be reflected.
Consistent with the results of MESDA (Fig 2A), we observed a substantial decline in the lev-
els of FL transcript (+5,7 variant) with a concomitant increase in the levels of Δ5,7 splice vari-
ant in all examined tissues of PQ-treated animals (Fig 3B). At the same time, the levels of Δ7
transcript were not affected by the conditions of OS in any samples except for heart. In this
organ, skipping of exon 7 increased slightly but significantly (Fig 3B). Further, individual skip-
ping of exon 5 showed a trend of decreasing under OS, although this decrease was not statisti-
cally significant (Fig 3B). Of note, Ct value for amplification of this transcript was highest
(between 34 and 37) among all splice variants whose levels we tested by QPCR. The results of
QPCR also revealed that OS induced by PQ promoted skipping of SMN2 exon 3 (Fig 3B). Note
that because of the primer design, transcripts with individually skipped exon 3 as well as tran-
scripts with co-skipped exons 3, 5 and 7 will also be amplified in this QPCR. As per MESDA
results, the levels of the latter transcripts were increased in PQ-treated animals (Fig 2A). Due
to technical limitations, we were unable to validate the levels of specific transcripts (such as
Δ3,7 and Δ3,5,7) by QPCR. We also used brain samples to quantify intron-retained products.
Except for a reduced rate of retention of SMN2 intron 1, our results of QPCR revealed no sig-
nificant difference in intron retention between normal and PQ-treated samples (S4 Fig). Thus,
enhanced skipping of exons, individual or multiple, appears to be the major consequence of OS
for SMN2 splicing.
Oxidative stress differentially affects splicing of various SMN2 exons in
reproductive organs
We also examined the relative abundance of various SMN2 transcripts in mouse reproductive
organs harvested at 24 h post PQ treatment. Consistent with previous reports in two different
mouse models of SMA [32,52], we observed FL SMN2 transcript as the major splice isoform in
testis of untreated animals. Similar to a recent report employing a mild mouse model of SMA
[32], testis of untreated TG mice showed noticeably higher levels of SMN2 exon 5 skipping
compared to other organs (Fig 4). We also detected low levels of co-skipping of SMN2 exons 5
and 6 (Fig 4A). Interestingly, PQ treatment did not produce significant changes in the splicing
of any of the SMN2 exons (Fig 4A). We observed only a small decrease in the levels of the FL
transcripts (Fig 4A). The relative levels of various SMN2 transcripts in uterus/ovary with or
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without PQ treatment were almost identical to those observed in brain or spinal cord (compare
Figs 4A and 2A).
We also performed QPCR to determine the frequency of specific splicing events in PQ-
treated reproductive organs. As a control we used brain from the same animal. Validating the
results of MESDA (Fig 4A), we observed no appreciable change in the splicing pattern of any
of the SMN2 exons in testis of TG mice injected with PQ (Fig 4B). Similar to brain, enhanced
skipping of SMN2 exons 3, 5 and 7 were major events in uterus/ovary of TG mice treated with
PQ (Fig 4B). Also, most of the OS-induced skipping of SMN2 exon 5 in uterus/ovary occurred
in transcripts that lacked exon 7.
Fig 3. QPCR for specific splicing events of SMN2 in different tissues of TGmice. (A) Diagrammatic representation of SMN2 transcript. Ovals indicate
alternatively spliced exons of SMN2. Annealing positions and names of primers used for QPCR are shown. (B) Frequency of specific splicing events of
SMN2 in different tissues. PQ treatment and tissue collection were the same as described in Fig 2A. QPCR products are indicated with names of skipped (Δ)
or included (+) exons. Primer combinations used for QPCR are given in parenthesis. Expression levels relative to PBS treated brain for each isoform were
normalized to value of 1. Error bars represent standard error. Stars above PQ bars indicate statistical significance (*, P < 0.05; **, P < 0.01). Abbreviations
are the same as in Fig 2A.
doi:10.1371/journal.pone.0154390.g003
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Suboptimal splice sites contribute towards oxidative-stress-induced
aberrant splicing of exons
To assess the potential contribution of cis-regulatory elements and splice sites to OS-induced
aberrant splicing, we compared sequences of seven exons whose skipping was increased by OS
(Fig 5A and 5B). We also analyzed their flanking intronic sequences. Except for SMN2 exon 5
and 7, other exons were chosen randomly. The OS-induced changes in the splicing pattern of
these exons were assessed by RT-PCR, using cDNAs from brain generated with oligo(dT)12-18.
For the PCR step, we used primers that annealed to sequences of exons that flank an OS-sensi-
tive exon of interest. Usually exons that are included have G residues at their first and last posi-
tions [53,54]. Underscoring the weak 30 and/or 50 ss as the possible contributor to exon
skipping under the conditions of OS, five of the seven skipped exons lacked the preferred R
(purine) and/or G residues at the first and/or the last positions of exons, respectively. Excep-
tions to this rule were exon 6 of Tcerg1 and exon 18 of Smarcc2. The splice sites of these exons
might be suboptimal due to other reasons. For instance, the presence of a U residue at the 5th
position of Tcerg1 intron 6 shortens the region base-paired with U1 snRNA, thus, hampering
an efficient recruitment of the U1 snRNP to the 50 ss of Tcerg1 exon 6 (Fig 5A).
We also analyzed splice sites of five alternatively spliced exons that we found to be included
in response to OS caused by PQ (Fig 5A and 5B). All of these candidate exons had a favorable
R residue at the first exonic position. Four of these exons also had a favorable G residue at the
last exonic position. Under normal conditions, three of the five exons were predominantly
skipped (Fig 5B; Plod2 exon 14, Uspl1 exon 2 and Atxn2 exon 10). All of these exons appear to
have suboptimal 50 ss due to poor base pairing between U1 snRNA and the 50 ss (Fig 5A).
Several studies have implicated the role of RNA structure in regulation of SMN2 exon 7 splic-
ing [55–57]. In particular, we have demonstrated that the 50 ss of SMN exon 7 is sequestered by a
terminal stem-loop structure (TSL2), as well as by an internal stem formed by the long-distance
interaction (ISTL1) [56,57]. We also analyzed the structural context of other eleven OS-sensitive
exons described in Fig 5A and 5B. For most exons, the predicted structure showed a strong termi-
nal or internal stem encompassing the 50 ss or its vicinity (Fig 5C). However, we did not observe
any structure(s) specific for exon exclusion versus inclusion triggered by OS.
We then analyzed what motifs were enriched within these twelve exons and their flanking
intronic sequences. Two hexameric motifs (MAYCAM and AKYMAR), a purine-rich motif
(ARAGA) and a GC-rich motif (CTGKRY) were present respectively in seven, six and five
exons skipped under OS (S5A Fig). In addition, two (AKWGST and ACAG) and four motifs
(CCCT, GYRRGT, GCTTWC andWGWGRA) were enriched in upstream and downstream
introns of most of these skipped exons (S5A Fig). At the same time, four motifs (ACWMRG,
GBTCA, GWAR and CCAAVT) were enriched in at least four of the five exons that showed
increased inclusion in response to OS (S5B Fig). In addition, two (MASAMA and TSCMTS)
and three motifs (SCWC, CAWAM and ACTA) were present respectively in upstream and
downstream introns of these exons (S5B Fig). The variety of the above-listed enriched motifs
suggests involvement of multiple protein factors in splicing regulation of these exons under
normal and OS conditions.
Fig 4. Effect of PQ treatment on splicing of SMN2 and Smn in reproductive organs of TGmice. (A)
MESDA of SMN2 in testis and uterus/ovary harvested from a TGmouse treated with PBS or PQ (70 mg/kg).
Samples were harvested at 24 h post PQ treatment. Labeling and other details are the same as in Fig 2A.
Percentages of major splice isoforms are indicated at the bottom of the gel. Abbreviations: BRN, brain; TST,
testis; UT/OV, uterus/ovary. (B) Comparison of splice variants of SMN2 in the indicated tissues of TG mice
determined by QPCR. The descriptions of QPCR are the same as in Fig 3. Abbreviations are the same as in
panel A. (C) MESDA of Smn in testis and uterus/ovary harvested from the same animal as in panel A.
doi:10.1371/journal.pone.0154390.g004
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Effect of oxidative stress on levels of SMN protein and regulatory factors
in TG brain
To interrogate the role of factors that affect splicing and post-splicing events of SMN2 under
the conditions of OS in vivo, we examined the levels of several proteins in TG brain within the
first 24 h of PQ treatment. We began with the determination of SMN levels, since an OS-
induced decline in SMN levels will have a direct impact on snRNP assembly and genome-wide
perturbations of splicing. Both Smn and SMN2 contribute to the overall SMN pool in TG mice.
Hence, we used two different antibodies to distinguish human SMN (hSMN) from total SMN
(hSMN + mSmn). Because of the overwhelming skipping of SMN2 exons 5 and 7 induced by
OS (Figs 2A, 3B and 4B), we expected to see a decline in the levels of hSMN in brain of TG ani-
mals injected with PQ. We observed only a small but statistically significant reduction in
hSMN in TG brain subjected to OS (Fig 6). A small decline in hSMN did not significantly
change the total levels of SMN in TG brain subjected to OS (Fig 6). Of note, we confirmed that
all SMN splice variants are capable of being translated when expressed ectopically in HeLa cells
(S6 Fig). However, we did not detect any hSMN isoforms including those corresponding to
SMN2ΔC7 and SMN2ΔC5,7 transcripts, the major splice isoforms observed under OS condi-
tions. Skipping of SMN2 exon 7 results in the generation of a protein degradation signal at the
C-terminus of SMN [19]. Since skipping of exon 7 occurred in all prominent splice isoforms
generated under OS, the degradation signal was the likely cause why we were unable to detect
these proteins.
Gemin2 tightly interacts with SMN and contributes towards most (if not all) SMN-associ-
ated functions [20]. We did not observe a significant change in Gemin2, suggesting that the
SMN-Gemin2 complex is not a limiting factor during the first 24 h of PQ-induced OS (Fig 6).
Eukaryotic initiation factor eIF4A2 is involved in microRNA-mediated translational repression
[58]. PQ-induced OS did not alter eIF4A2 level (Fig 6), suggesting that the general microRNA-
mediated translation suppression is unlikely to be triggered during the initial stages of OS.
Consistent with the insignificant change in the levels of serine/arginine (SR)-phosphorylating
protein SRPK in TG brain subjected to OS, we did not observe a general change in the phos-
phorylation status of splicing factors (Fig 6). Nonetheless, these results should be treated with
caution because enhanced phosphorylation of one protein could be masked by dephosphoryla-
tion of another protein of similar size. Further, SF2/ASF, an SR protein, has been previously
implicated in strengthening of the 30 ss of SMN exon 7 [59]. The strength of a 30 ss could also
be altered by hnRNP K, a critical splicing factor with important role in neuronal differentiation
[60]. However, we did not observe any significant OS-induced changes in levels of these pro-
teins in TG brain (Fig 6).
Splicing factors hnRNP A1 and hnRNP A2 are known negative regulators of SMN2 exon 7
splicing [61,62]. These two proteins interact with both exon 7 and intron 7 of SMN2 [63].
While levels of hnRNP A1 in TG brain subjected to OS remained unaffected, we observed a
small but statistically significant decrease in the level of hnRNP A2 (Fig 6). These results sug-
gest that the rules of exon skipping under conditions of OS might be governed by factors that
are not necessarily negative regulators. Indeed, we observed a small but noticeable decrease in
the level of TIA1, a glutamine-rich protein that serves as a key regulator of stress granule
Fig 5. Analyses of splice sites of OS-sensitive exons of SMN2 and other murine genes. (A) Names of exons and their sizes are indicated. Nucleotides
involved in the base paring between the 50 ss of a given exon and U1 snRNA are marked by solid horizontal bars on the top of each sequence. Exonic
sequences are indicated by uppercase letters, while introns are indicated by lowercase letters. Skipping of exons numbered 1–7 within red ovals is
increased, while skipping of exons numbered 8–12 within green ovals is decreased upon PQ treatment. (B) Splicing pattern of OS-sensitive exons in the
presence of PBS or PQ treatment. PQ treatment and tissue collections were same as described in Fig 2A. (C) Manually predicted secondary structures of the
50 ss of OS-sensitive exons. Arrowheads indicate the 50 ss.
doi:10.1371/journal.pone.0154390.g005
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Fig 6. Effect of PQ treatment on the levels of various proteins in the brain of TGmice. PQ treatment and tissue collections were the same as described
in Fig 2A. (A) Western blots showing the expression levels of SMN, and the indicated proteins in PBS or PQ-treated TG brain. PQ treatment and brain
collection were the same as described in Fig 2A. Depending on the protein of interest 10, 20 or 30 μg of total lysate was loaded per lane. The same
membrane was stripped and re-probed for evaluation of up to four target proteins. Equal protein loading was confirmed by re-probing the blot with antibodies
against β-actin and GAPDH. Names of the probed proteins are indicated on the left of the blot. (B) Densitometric analysis of Western blots shown in panel A.
Stars above bars indicate statistical significance (*, P < 0.05).
doi:10.1371/journal.pone.0154390.g006
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formation. We have previously reported TIA1 as a positive regulator of SMN2 exon 7 splicing
[45]. Similar to TIA1, PSF is another glutamine-rich protein that stimulates SMN2 exon 7
inclusion. Based on sequence homology, PSF is grouped along with p54nrb/NONO proteins
[64]. However, unlike TIA1, we did not find a statistically significant change in the levels of
PSF and p54nrb proteins in TG brain upon PQ treatment (Fig 6). Level of another splicing fac-
tor, SRp55, that is known to interact with the 50 ss of an exon [65], showed a noticeable but sta-
tistically insignificant increase in PQ-treated brain (Fig 6).
Proteome analysis reveals a role for hnRNP H in OS-induced
downregulation of SMN
To capture novel regulatory factors that are likely to affect level of SMN under OS conditions,
we employed a two-dimensional (2D) gel electrophoreses of lysates prepared from TG brains
harvested at 24 h post PQ treatment. We performed two independent experiments to ensure
the reproducibility of our findings. After comparing the results of 2D gel electrophoresis, we
investigated four protein spots that were significantly altered in brains subjected to OS (Fig
7A). We analyzed these proteins by mass spectrometry using MALDI-TOF and LC/MS (S2
Table). These proteins were identified as lactate dehydrogenase B (LDHB), phosphoglycerate
mutase 1 (PGAM1), alpha-enolase 1 (ENO1) and hnRNP H. While LDHB and PGAM1 were
found to be upregulated, ENO1 and hnRNP H were found to be downregulated (Fig 7B). To
determine whether the altered expression of the above proteins was due to changes in tran-
scription, we performed QPCR. Consistent with the OS-induced downregulation of ENO1 and
hnRNP H proteins, we observed a small but statistically significant decrease in their transcripts
(Fig 7C). However, we did not capture a significant change in Ldhb and Pgam1 transcripts in
PQ-treated brain, suggesting that posttranslational modification(s) cause differential expres-
sion of LDHB and PGAM1 (Fig 7C). Considering that ENO1, LDHB and PGAM1 are involved
in glycolysis and/or gluconeogesis pathways, their alteration during OS was not surprising. In
particular, downregulation of ENO1 in striatum of PQ-treated mice mimicking Parkinson’s
disease has been previously reported [66].
A recent study precluded the role of hnRNP H in SMN exon 7 splicing, since the depletion
of this protein did not affect splicing of exon 7 [67]. However, the effect of hnRNP H has not
been tested in splicing of other SMN exons. Moreover, the conditions of OS could cause post-
translational modifications in hnRNP H. Such modified hnRNP H can then affect splicing of
SMN2 exons. Having detected the OS-induced downregulation of hnRNP H in our proteome
analysis, we performedWestern blot to determine whether the conditions of OS cause a general
decline in expression of hnRNP H. We did not capture a statistically significant decrease in the
level of hnRNP H in brain of TG mice treated with PQ (Fig 7D). These results suggest that the
change in the level of hnRNP H captured in proteome analysis is likely due to post-transla-
tional modification(s). To independently validate these findings in the context of a human cell
line, we performed experiments in SH-SY5Y cells as previously described [41]. Similar to the
results obtained in TG brain, we observed no significant decrease in the level of hnRNP H in
SH-SY5Y cells treated with PQ (S7 Fig). We also performed similar experiment in SMA patient
fibroblasts (GM03813 cells) and observed no significant change in the level of hnRNP H in
PQ-treated fibroblasts (S7 Fig).
Discussion
Here we report a comprehensive analysis of OS-induced aberrant splicing of multiple exons of
SMN2, an ubiquitously expressed human gene associated with SMA, which is the most fre-
quent genetic cause of infant mortality. We employed a healthy transgenic (TG) mouse model
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to assess the tissue-specific effect of PQ-induced OS on splicing of various SMN2 exons. We
chose PQ based on its classical usage across different animal species to study the molecular
mechanisms of OS [68–70]. In a most revealing manner, our results of MESDA, RT-PCR and
QPCR demonstrated body-wide susceptibility of various SMN2 exons to OS conditions in TG
mice (Figs 1–4; S2 Fig). Barring testis, all tissues exposed to PQ showed near total disappear-
ance of the FL transcript, while transcripts in which exon 7 was skipped alone or together with
exon 5 were the major splice isoforms. Of note, while levels of ΔC5,7 transcript significantly
increased in a tissue-independent manner, level of ΔC7 transcript was not significantly affected
by OS (Fig 3). These results suggest that the OS-induced skipping of exon 7 triggered skipping
of exon 5 or vice versa. The effect of OS on SMN2 exon 3 splicing was also tissue-independent
(Fig 3). The skipping of this exon predominantly occurred in combination with the skipping of
other exon(s). Splicing of Sbp2 exons 3/3a suggested that the conditions of OS could favor
usage of an alternative splice site within an existing exon. However, none of the OS-induced
SMN2 splicing events was associated with an alternative splice site usage.
The results of MESDA indicate that expression of ΔC7 and ΔC5,7 transcripts in the liver of
TG mice peaked at 8 h and 24 h post PQ treatment, respectively (Fig 1B). It is likely that early
skipping of SMN2 exon 7 in OS is brought about by sudden change in the posttranslational
modifications and/or nuclear import/export of splicing factors, whereas delayed skipping of
exon 5 is affected by subsequent changes, such as a slow rate of transcription elongation. Gen-
erally, a faster rate of transcription elongation favors exon skipping due to the lack of time for
the recruitment of factors that define splice sites [71]. Our finding of an OS-induced reduction
in the retention of intron 1, the largest SMN intron, might support that a slow elongating RNA
polymerase II helps recruit critical splicing factor(s) for a fast removal of intron 1. However, a
slow elongating RNA polymerase II may also recruit negative factors, leading to enhanced skip-
ping of downstream exons. Consistently, a recent report supports recruitment of an inhibitory
factor during slow transcription elongation leading to the skipping of exon 9 of CFTR [72]. It is
possible that slow removal of intron 1 under normal conditions is designed to hold the partially
spliced SMN transcripts in the nucleus until other introns are excised. However, it remains to
be seen how the rate of SMN transcription affects the splicing of various SMN exons.
Transcription and splicing of a large number of genes are differently regulated in mamma-
lian testis [73,74]. We have recently shown that the levels of Smn protein in testis of mice are
more than a magnitude higher than in most tissues, including brain, spinal cord, heart, liver,
lung and kidney [32]. It appears that the high level of SMN in human testis is maintained at
least in part due to the presence of SMN2 that goes through an adult-specific splicing switch to
generate mostly FL transcripts [32]. While the mechanism of this unique splicing switch
remains to be uncovered, we hypothesize that the high level of SMN in testis is necessary to
maintain the sufficient levels of functional snRNPs for the heightened splicing activity during
spermatogenesis. In addition, low SMN causes c-Jun NH2-terminal kinase (JNK) signaling
pathway activation that is associated with the testicular toxicity [23,75,76]. Therefore, main-
taining a high level of SMN in testis is critical for sustaining general testicular health. It is
known that low SMN exacerbates skipping of SMN2 exon 7 [77]. Hence, high SMN level might
Fig 7. Proteome analysis of brain from PBS and PQ treated TGmice. PQ treatment and tissue collections were the same as described in Fig 2A. (A)
Two-dimensional iso-electric focusing and SDS polyacrylamide gel electrophoresis (2D-IEF-SDS-PAGE) of PBS and PQ-treated TG brain. Differentially
expressed proteins are indicated by arrows. (B) Amplified spots from panel A were identified by MALDI-TOF MS analysis. Target proteins are magnified. The
bar diagrams show the relative expression of identified proteins in the absence and presence of PQ. Error bars represent standard error. Stars above bars
indicate statistical significance (*, P < 0.05). (C) Levels of various transcripts determined by QPCR in samples used in panel A. (D) Western blot showing the
effect of PQ treatment on the level of hnRNP H in the brain of TG mice. PQ treatment and tissue collection were the same as described in Fig 2A. Details of
Western blot are the same as described in Fig 6.
doi:10.1371/journal.pone.0154390.g007
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at least partly contribute to the prevention of OS-induced skipping of SMN2 exons in testis. In
addition, it is possible that splicing factors responsible for the splicing switch of SMN2 in this
organ are not affected by PQ-induced OS. It is also likely that the blood testis barrier is less per-
meable to PQ. Hence, PQ might not penetrate the testis in amount sufficient enough to pro-
duce a significant effect on splicing of the SMN2 exons. Supporting this argument, an early
study on PQ poisoning in Crete detected markedly less PQ accumulation in testis compared to
other tissues, including kidney, liver and lung [78].
Promoters of human SMN and mouse Smn genes share several but not all motifs [79]. How-
ever, since none of the Smn exons showed skipping under the normal and OS conditions (Fig
2B), we hypothesize that human-specific promoter elements and/or cis-elements within tran-
scribed pre-mRNA are the driving force of splicing regulation of SMN exons. While a direct
role of a promoter element(s) on splicing of SMN exons is yet to be established, a number of
exonic and intronic cis-elements that weaken the 30 and 50 ss of SMN2 exon 7 have been impli-
cated in skipping SMN2 exon 7 [63]. It has also been shown that the sequestration of a negative
cis-element by an 8-mer ASO prevents skipping of SMN2 exon 7 under normal and OS condi-
tions [41,80–82]. Hence, a correlation could be drawn between a suboptimal splice site and sus-
ceptibility to aberrant splicing under conditions of OS. Genome-wide analyses show the
prevalence of R (purines) and G residues at the first and the last positions of human exons,
respectively [53]. In our study, most exons susceptible to skipping induced by OS lacked the
favorable residues at the first and the last positions of exons (Fig 5A). Lack of a G residue at the
last position of an exon weakens the base pairing between U1 RNA and the 50 ss. In several
cases we examined, the RNA:RNA duplex formed between U1 RNA and the 50 ss appeared to
be weak due to less than six continuous base pairs (Fig 5A). Exons that were susceptible to
inclusion induced by OS appeared to have favorable residues at the terminal exonic positions.
Yet, the 50 ss of most of these exons had poor base pairing with U1 RNA (Fig 5A). We have pre-
viously shown an inhibitory structural context as one of the limiting factors for skipping of
SMN2 exon 7 [83]. Most of the exons we examined had predicted stem-loop structures that
sequester their 50 ss (Fig 5C). We also observed enrichment of several motifs within OS-sensi-
tive exons and their flanking intronic sequences (S5 Fig). The compositions of enriched motifs
in skipping-prone exons were distinct from those in inclusion-prone exons. Future experi-
ments will determine how these motifs cooperate to regulate alternative splicing under OS.
OS caused a small but statistically significant decrease in hSMN protein derived from
SMN2. Due to the insertion of a protein degradation signal upon skipping of exon 7 [19], we
were unable to detect proteins translated from aberrantly spliced SMN2 transcripts, the major-
ity of which lacked exon 7. Despite being translation compatible, none of the alternatively
spliced variants of human SMN have been assigned any specific function. It is possible that
SMN2 transcripts generated under OS play some role. For example, the short SMN2 isoforms
could act as long-noncoding RNAs (lncRNAs). One of the critical functions of lncRNAs is to
serve as competing RNAs to sequester microRNAs and RNA-binding proteins [84,85]. Consid-
ering FL and truncated SMN2 transcripts generated under OS possess identical 30 untranslated
regions (30UTRs), they might compete for the same factors that regulate translation via
30UTRs. Therefore, the reason for only a small reduction in FL SMN level despite a significant
drop in level of FL transcript could be the enhanced translation of FL transcripts due to the
30UTRs of the short SMN2 transcripts generated under OS acting as a “sponge” for the inhibi-
tory microRNA.
Even though we did not capture a major shift in OS-induced expression of several splicing
factors, we did observe a small but significant decrease in levels of TIA1 and hnRNP A2. These
proteins have the opposite effects on SMN2 exon 7 splicing [82]. While TIA1 promote inclu-
sion of exon 7, hnRNP A2 promotes exclusion of exon 7. Although not statistically significant,
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we also observed a noticeable increase in the level of SRp55. The role of SRp55 has been impli-
cated in the inhibition of the 50 ss of exon 3 of HIV-1 vpr mRNA [65]. Recently, SRp55 was
shown to inhibit SMN exon 7 splicing [67]. Changes in the levels of splicing factors described
in this study do not fully capture the overall mechanistic aspects by which splicing of various
SMN exons are regulated under normal and OS conditions. Future studies should focus on
how splicing of specific SMN exons are regulated. Despite the fact that an overwhelming OS-
induced skipping of SMN2 exon 7 (together with exon 5) was recorded in most tissues, it
wouldn’t be surprising that an entirely different set of splicing factors are involved in splicing
of these exons in different tissues. Evidence supporting this argument comes from our parallel
experiment with Sbp2. Every tissue examined showed a different pattern of Sbp2 exon 3/3a
usage under OS conditions (Fig 2C).
Our proteome analysis revealed downregulation of hnRNP H as one of the consequences of
PQ-induced OS (Fig 7). Our follow-up experiments suggested that the differential expression
of hnRNP H captured in the proteome analysis is likely due to a posttranslational modification
(s). In addition to its effect on splicing, there are other mechanisms by which hnRNP H could
regulate level of SMN under normal and OS conditions. For instance, the involvement of
hnRNP H in regulation of 30-end processing has been shown for human β-globin and p53 tran-
scripts [86,87]. Interestingly, a transcriptome-wide analysis employing CLIP-seq revealed
direct interaction of hnRNP H with SMN exon 8 [88]. Future studies will determine if hnRNP
H plays any role in splicing and/or 30-end processing of SMN transcripts. While this is the first
in vivo study to show the effect of a single high dose of an OS-inducing agent on splicing of var-
ious exons of SMN in different tissues, outcomes are likely to vary if animals are exposed to an
OS-inducing agent for a longer duration. Also, the background and/or the age group of mice
are likely to influence the effect of OS on splicing of various SMN exons. Addressing these
questions will provide a better understanding of the role of SMN in diseases caused by OS.
Conclusion
In conclusion, our findings demonstrate the susceptibility of various SMN2 exons to skipping
under the conditions of OS and implicate multiple cis-elements and transacting factors in splic-
ing regulation of different SMN exons under normal and OS conditions.
Supporting Information
S1 Fig. Effect of PQ treatment on animal survival as well as on the level of molecular mark-
ers for OS. (A) Effect of PQ on survival of TG mice. Kaplan-Meier survival analysis of TG
mice injected with PQ (70 mg/kg). N indicates number of mice used for this study. (B) Western
blot analysis demonstrating the levels of 4-Hydroxynonenal adducts of histidine residues in
response to PQ treatment. Brain samples were collected at 0 h (control) and 8 h post PQ injec-
tion. We used 35 μg of total protein for each sample. β-actin was used as a loading control.
Densitometric analysis of Western blots is shown in the right panel. Stars indicate statistical
significance (, P< 0.05). AU, arbitrary units. (C) Western blot analysis demonstrating the
expression of total and phosphorylated AKT (pAKT) protein in brain of control or PQ-treated
animals. Brain samples were collected at 0 h (control) and 8 h post PQ injection. We used
50 μg of total protein for each sample. Names of probed proteins are indicated on the left of
each blot. Sizes of proteins based on molecular weight markers are indicated on the right of
each blot. β-actin was used as a loading control. Densitometric analysis of Western blots is
shown in the right panel. Bars represent the relative expression of pAKT versus AKT proteins.
Stars indicate statistical significance (, P< 0.05). AU, arbitrary units.
(TIF)
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S2 Fig. Effect of PQ treatment on splicing of various exons of human SMN2 and mouse
Smn in different tissues of TG mice. (A) Diagrammatic representation of exon-intron organi-
zation of SMN2 and Smn. Exons are indicated as colored boxes, while introns are shown as
lines. Sizes of introns and exons are given as well. (B) In vivo splicing pattern of exon 7 in
SMN2 and Smn in different tissues of mice injected with PBS (-) or PQ (+). Names of tissues
are indicated at the top of the gel. The upper band corresponds to a product that includes exon
7, while the lower band corresponds to a product in which exon 7 is skipped. The percentage of
exon 7 skipping is given at the bottom of the gel. It was calculated from the total value of exon
7-included and exon 7-skipped products. SMN2 products were amplified using human-specific
primers annealing to exon 6 (N-24) and exon 8 (P2-2). For Smnmouse-specific primers
annealing to exons 6 (5SmnE6) and 8 (3SmnE8) were used. Abbreviations: E7, exon 7. (C) In
vivo splicing pattern of exon 5 in SMN2 and Smn in different tissues of mice injected with PBS
(-) or PQ (+). Descriptions are the same as in panel A. SMN2 products were amplified using
human-specific primers annealing to exon 4 (5SMNE4) and exon 6 (3SMNE6). For Smn,
mouse-specific primers annealing to exons 4 (5SmnE4) and 6 (3SmnE6) were used. Abbrevia-
tions: E5, exon 5. (D) In vivo splicing pattern of exon 3 of SMN2 and Smn in different tissues of
mice injected with PBS (-) or PQ (+). Descriptions are the same as in panel A. Human-specific
primers annealing to exons 1 (5SMNE1) and 4 (3SMNE4) and mouse-specific primers anneal-
ing to exons 1 (5SmnE1) and 4 (3SmnE4) were used for amplification of SMN2 and Smn prod-
ucts, respectively. Abbreviations: E3, exon 3.
(TIF)
S3 Fig. Alignment of sequences corresponding to mouse Sbp2 (mSbp2) and human SBP2
(hSBP2) exon 3 and its flanking intronic sequences. (A) Sequence alignment was done using
MacVector software. Nucleotides numbered as -1, 1 and +1 correspond to the last position of
intron 2, the beginning of exon 3 and the start of intron 3, respectively. Exon 3 is split into exon
3a (purple) and exon 3b (green). Arrows indicate the splice sites. Stars indicate positions of
sequence identity. (B) Recognition of the 50 ss ofmSbp2 exon 3 by U1 snRNA. The 50 ss:U1
snRNA base pairing is indicated by the vertical lines. (C) Secondary structure predicted to form
at the 50 ss ofmSbp2 exon 3. Uppercase letters correspond to nucleotides of exon 3, lowercase let-
ter to nucleotides of intron 3. (D) The effect of PQ on splicing of SBP2. Diagrammatic representa-
tion of SBP2 alternative splicing under normal and oxidative-stress conditions is shown in the left
panel. In vivo splicing pattern of SBP2 in different cell lines in the presence (+) or absence (-) of
PQ is shown in the right panel. Names of cell lines used are given at the top of the gel. The identity
of splice isoforms is indicated on the right of the gel. To amplify SBP2 splice isoforms human-spe-
cific primers annealing to exon 1 (5hSBP2E1) and 4 (3hSBP2E4) were employed.
(TIF)
S4 Fig. Effect of PQ on intron retention during SMN2 splicing. (A) Diagrammatic representa-
tion of intron-retained SMN2 transcripts. Exons are indicated as colored boxes. Alternatively
spliced exons 3, 5 and 7 are indicated as colored ovals. Introns are shown as lines. Name of the
splice isoforms are given on the left of each diagram. Of note, only one out of many splice variants
with a specific retained intron is shown. Annealing positions and names of primers used for
QPCR are indicated. To detect intron retention, we used a primer pair in which a forward primer
annealed within the exon and a reverse primer annealed to the intron of interest in the vicinity of
the 50 ss. cDNA was reverse transcribed using random primers and total RNA prepared from
brain of PBS and PQ treated animals. (B) Quantification of intron retention by QPCR. Expression
levels relative to PBS treated brain for each isoform were normalized to value of 1. Error bars rep-
resent standard error. Stars above PQ bars indicate statistical significance (, P< 0.05).
(TIF)
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S5 Fig. Analyses of motifs enriched within exons whose splicing was sensitive to OS. Intro-
nic sequences that flank these exons were included in the analysis as well. (A) Enriched motifs
of OS-sensitive exons that showed enhanced skipping under PQ-induced OS. (B) Enriched
motifs of OS-sensitive exons that showed enhanced inclusion under PQ-induced OS.
(TIF)
S6 Fig. Efficiency of translation of various SMN2 isoforms generated by alternative splic-
ing. (A) Diagrammatic representation of SMN domain structure. Exons, the number of amino
acids they encode, protein domains and their functions are all indicated. The UTRs, the start
and the stop codons are marked. Abbreviations: UTR, untranslated region. (B) Diagrammatic
representation of FLAG-tagged SMN splice isoforms cloned into pCI-NEO mammalian
expression vector (S3 Table). Names of the protein isoforms as well as their expected sizes are
shown on the right of each construct. Exons are shown as colored boxes. Broken lines indicate
skipped exons. (C) Expression of FLAG-tagged SMN protein isoforms in HeLa cells transfected
with mammalian expression vectors described in panel B as determined by Western blot.
Name of each protein isoform is indicated at the top of the blot. Names of probed peptide/pro-
teins are indicated on the left. β-actin was used as a loading control.
(TIF)
S7 Fig. Effect of PQ treatment on levels of hnRNP H protein in human cell lines. Pre-plated
SH-SY5Y (A) and GM03813 (SMA patient fibroblasts) (B) cells were treated with 1 mM of PQ
for 24 hours, after which the cells were collected for preparation of protein lysates. Top panels,
labeled MESDA, indicate multiple-exon-skipping events in endogenous SMN1/SMN2 genes in
the absence (-) or presence (+) of PQ. Spliced isoforms were amplified using primers annealing
to exon 1 (5SMNE1TSS) and exon 8 (3E8-25). The identities of spliced isoforms are marked on
the left of the gel. Bottom panel, labeled Western blot, shows the levels of hnRNP H protein
in SH-SY5Y (A) and GM03813 (B) cells in the absence (-) or presence (+) of PQ. 20 and 10 μg
of proteins were loaded from SH-SY5Y and GM03813 lysates, respectively. β-actin was used
as a loading control. Densitometric quantifications are given as well. Abbreviations: FL, full
length.
(TIF)
S1 Table. List of primers used for PCR and QPCR.
(DOCX)
S2 Table. A list of altered proteins from PQ treated TG brain.
(DOCX)
S3 Table. Description and GenBank accession numbers of mammalian expression vectors.
(DOCX)
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